www.reuters.com
Open in
urlscan Pro
2600:9000:21b8:6400:15:5a3e:9d40:93a1
Public Scan
URL:
https://www.reuters.com/business/healthcare-pharmaceuticals/blood-your-hands-if-world-steps-back-tackling-covid-now-who-...
Submission: On December 06 via api from US — Scanned from US
Submission: On December 06 via api from US — Scanned from US
Form analysis
0 forms found in the DOMText Content
Skip to main content Report this ad Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv * World Browse World * Africa * Americas * Asia Pacific * China * Europe * India * Israel and Hamas at War * Japan * Middle East * Ukraine and Russia at War * United Kingdom * United States * Reuters NEXT * Business Browse Business * Aerospace & Defense * Autos & Transportation * Davos * Energy * Environment * Finance * Healthcare & Pharmaceuticals * Media & Telecom * Retail & Consumer * Future of Health * Future of Money * Take Five * World at Work * Markets Browse Markets * Asian Markets * Carbon Markets * Commodities * Currencies * Deals * Emerging Markets * ETFs * European Markets * Funds * Global Market Data * Rates & Bonds * Stocks * U.S. Markets * Wealth * Macro Matters * Sustainability Browse Sustainability * Boards, Policy & Regulation * Climate & Energy * Land Use & Biodiversity * Society & Equity * Sustainable Finance & Reporting * The Switch * Reuters Impact * COP29 * Legal Browse Legal * Government * Legal Industry * Litigation * Transactional * US Supreme Court * Breakingviews Browse Breakingviews * Breakingviews Predictions * Technology Browse Technology * Artificial Intelligence * Cybersecurity * Space * Disrupted * Investigations * More Sports * Athletics * Baseball * Basketball * Cricket * Cycling * Formula 1 * Golf * NFL * NHL * Soccer * Tennis Science Lifestyle Graphics Pictures Wider Image Podcasts Fact Check Video Sponsored Content * Reuters Plus * Press Releases Live My News Sign InSubscribe Healthcare & Pharmaceuticals 'BLOOD ON YOUR HANDS' IF WORLD STEPS BACK ON TACKLING COVID NOW, WHO OFFICIAL SAYS By Jennifer Rigby September 23, 20228:17 AM HSTUpdated 2 years ago Text * Small Text * Medium Text * Large Text Share * X * Facebook * Linkedin * Email * Link Bruce Aylward, Senior Advisor to the Director-General of the World Health Organization (WHO), speaks during a news conference in Geneva, Switzerland, December 20, 2021. REUTERS/Denis Balibouse Purchase Licensing Rights, opens new tab * Companies * Pfizer Inc Follow LONDON, Sept 23 (Reuters) - If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization official told Reuters. In an interview, WHO senior adviser Bruce Aylward warned that richer nations must not step back from tackling COVID-19 as a global problem now, ahead of future potential waves of infection. In the last few weeks, WHO Director General Tedros Adhanom Ghebreyesus said the end of the pandemic was in sight, and U.S President Joe Biden said the pandemic was over. Advertisement · Scroll to continue "When I hear them say, 'Well, we're so comfortable here,' it's like, 'Great, now you can really help us get the rest of the world done'," said Aylward. Aylward said that the group he co-ordinates, which focuses on equitable access to COVID-19 vaccines, treatments and tests worldwide, is not yet ready to move out of the emergency phase of tackling the pandemic and that countries need to be ready and have treatments in place for any further waves of infection. Advertisement · Scroll to continue "If you go to sleep right now and this wave hits us in three months... God - blood on your hands," he said. He also stressed that Biden had a point domestically as the United States has good access to all COVID tools. It has also not cut its global commitment to fighting COVID, he added. Aylward co-ordinates the ACT-Accelerator, a partnership between WHO and other global health bodies to help poorer countries access COVID-19 tools. The effort, which includes the vaccine-focused COVAX, has reached billions of people worldwide but has faced criticism for not acting quickly enough. There had been some speculation that the effort may wind up this autumn, but Aylward said it was simply changing its focus as the pandemic changes. Over the next six months, the partnership will aim particularly at delivering vaccines to the roughly one quarter of the world's health care workers and elderly who have still not had a shot, as well as on improving access to test-and-treat particularly with Pfizer's Paxlovid, he said. It will also look to the future as COVID is "here to stay", and unless systems are put in place, support will collapse once other industrialised nations also think the pandemic is over, said Aylward. The initiative already has an $11 billion gap in its budget, with most of its available $5.7 billion in funding pledged towards vaccines rather than tests or treatments. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. Reporting by Jennifer Rigby; Editing by Hugh Lawson Our Standards: The Thomson Reuters Trust Principles., opens new tab * Suggested Topics: * Healthcare & Pharmaceuticals * COVID-19 Share * X * Facebook * Linkedin * Email * Link Purchase Licensing Rights Jennifer Rigby Thomson Reuters Jen is the Global Health Correspondent at Reuters, covering everything from pandemics to the rise of obesity worldwide. Since joining the news agency in 2022, her award-winning work includes coverage of gender-affirming care for adolescents in the UK and a global investigation with colleagues into how contaminated cough syrup killed hundreds of children in Africa and Asia. She previously worked at the Telegraph newspaper and Channel 4 News in the UK, and spent time as a freelancer in Myanmar and the Czech Republic. * Email * X READ NEXT * Healthcare & PharmaceuticalscategoryHealthcare industry rethinks risk after murder of UnitedHealth exec * WorldcategoryKiller of UnitedHealth's Thompson still at large amid manhunt in New York * Healthcare & PharmaceuticalscategoryFDA chief defends work on obesity, food to US Senate as agency awaits fierce critic RFK Jr * Healthcare & PharmaceuticalscategoryLilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars * Healthcare & PharmaceuticalscategoryThirteen children die in Mexico from possible IV bag contamination * Healthcare & PharmaceuticalscategoryNovo Nordisk to cut US list prices of two insulin products by more than 70% BUSINESS * AIRBUS DELIVERS 84 PLANES IN NOVEMBER Aerospace & Defensecategory · December 5, 2024 · 9:54 PM HST · 15 min ago Airbus delivered 84 planes in November as the planemaker moved back towards end-year targets after a downturn over the summer. * EnergycategoryOil prices dip as extended OPEC+ supply cuts highlight weak demand9:41 PM HST · Updated 27 min ago * Sustainable Finance & ReportingcategoryUK homebuilder Berkeley cautious on near-term demand after HY profit fall9:23 PM HST · Updated an hour ago * ANALYSISGas price shock set to add to Europe's industrial pain9:03 PM HST * categoryUK 'will think carefully' on retaliating if hit by Trump tariffs, business minister tells FT8:28 PM HST SITE INDEX LATEST * Home * Authors * Topic Sitemap * Archive * Article Sitemap BROWSE * World * Business * Markets * Sustainability * Legal * Breakingviews * Technology * Investigations * Sports * Science * Lifestyle MEDIA * Videos * Pictures * Graphics * Podcasts ABOUT REUTERS * About Reuters, opens new tab * Advertise with Us, opens new tab * Careers, opens new tab * Reuters News Agency, opens new tab * Brand Attribution Guidelines, opens new tab * Reuters and AI, opens new tab * Reuters Leadership, opens new tab * Reuters Fact Check * Reuters Diversity Report, opens new tab STAY INFORMED * Download the App (iOS), opens new tab * Download the App (Android), opens new tab * Newsletters INFORMATION YOU CAN TRUST Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. FOLLOW US * X * Facebook * Instagram * Youtube * Linkedin THOMSON REUTERS PRODUCTS * WESTLAW, OPENS NEW TAB BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT, ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY. * ONESOURCE, OPENS NEW TAB THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING TAX AND COMPLIANCE NEEDS. * CHECKPOINT, OPENS NEW TAB THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE PROFESSIONALS. LSEG PRODUCTS * WORKSPACE, OPENS NEW TAB ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE. * DATA CATALOGUE, OPENS NEW TAB BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS. * WORLD-CHECK, OPENS NEW TAB SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS. * Advertise With Us, opens new tab * Advertising Guidelines * Purchase Licensing Rights, opens new tab * Cookies, opens new tab * Terms of Use * Privacy, opens new tab * Digital Accessibility, opens new tab * Corrections * Site Feedback, opens new tab All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2024 Reuters. All rights reserved